aldosterone has been researched along with Hyperprolactinaemia in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " The aim of this study was to evaluate the relationship of nontumoural hyperprolactinemia with the activity of adrenocortical and RAA axis, before and after administration of bromocriptine." | 9.15 | The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia. ( Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG, 2011) |
| "These results suggest that hyperprolactinemia increases basal, angiotensin II- and KCl-stimulated aldosterone secretion by ZG cells in OVX rats through activation of T-type Ca2+ channels, the post-cAMP and protein kinase A pathway, cytochrome P450 side-chain cleavage enzyme, and aldosterone synthase, as well as by causing increased expression of steroidogenic acute regulatory protein in ZG cells." | 7.71 | Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats. ( Chang, LL; Ho, LT; Kan, SF; Kau, MM; Wang, PS, 2002) |
| " The aim of this study was to evaluate the relationship of nontumoural hyperprolactinemia with the activity of adrenocortical and RAA axis, before and after administration of bromocriptine." | 5.15 | The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia. ( Chlorou, A; Kotsa, K; Mediskou, P; Papazisi, A; Psarakou-Gotzamani, A; Tsekmekidou, X; Yavropoulou, MP; Yovos, JG, 2011) |
| "These results suggest that hyperprolactinemia increases basal, angiotensin II- and KCl-stimulated aldosterone secretion by ZG cells in OVX rats through activation of T-type Ca2+ channels, the post-cAMP and protein kinase A pathway, cytochrome P450 side-chain cleavage enzyme, and aldosterone synthase, as well as by causing increased expression of steroidogenic acute regulatory protein in ZG cells." | 3.71 | Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats. ( Chang, LL; Ho, LT; Kan, SF; Kau, MM; Wang, PS, 2002) |
| " The hyperprolactinemia, hypogonadotropic hypogonadism, hyperaldosteronism and hypokalemia subsided with the administration of bromocriptine 5 mg/day." | 3.68 | Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism. ( Tan, LG; Tan, SA, 1990) |
| "Seven women with untreated chronic hyperprolactinemia (HPRL) were included in the study." | 1.27 | Lack of prolactin involvement in corticosteroid secretion. ( Girard, F; Hugues, JN; Modigliani, E; Sebaoun, J, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mediskou, P | 1 |
| Yavropoulou, MP | 1 |
| Kotsa, K | 1 |
| Tsekmekidou, X | 1 |
| Psarakou-Gotzamani, A | 1 |
| Papazisi, A | 1 |
| Chlorou, A | 1 |
| Yovos, JG | 1 |
| Oki, Y | 1 |
| Yagi, T | 1 |
| Yoshimi, T | 1 |
| Mychka, VB | 1 |
| Chazova, IE | 1 |
| Dmitriev, VV | 1 |
| Masenko, VP | 1 |
| Kau, MM | 1 |
| Chang, LL | 1 |
| Kan, SF | 1 |
| Ho, LT | 1 |
| Wang, PS | 1 |
| James, VH | 1 |
| Tan, SA | 1 |
| Tan, LG | 1 |
| Smetnik, VP | 1 |
| Komarova, IuA | 1 |
| Hugues, JN | 1 |
| Modigliani, E | 1 |
| Girard, F | 1 |
| Sebaoun, J | 1 |
| Serri, O | 1 |
| O'Malley, BP | 1 |
| Mercey, D | 1 |
| Clarke, E | 1 |
| Maguire, M | 1 |
| Jackson, J | 1 |
| Rosenthal, FD | 1 |
1 review available for aldosterone and Hyperprolactinaemia
| Article | Year |
|---|---|
[Premenstrual syndrome].
Topics: Aldosterone; Body Weight; Brain; Dopamine; Endorphins; Estrogens; Female; Humans; Hyperprolactinemia | 1986 |
1 trial available for aldosterone and Hyperprolactinaemia
| Article | Year |
|---|---|
The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.
Topics: Adult; Aldosterone; Angiotensin II; Bromocriptine; Creatinine; Dopamine Agonists; Female; Humans; Hy | 2011 |
8 other studies available for aldosterone and Hyperprolactinaemia
| Article | Year |
|---|---|
Masked hyperprolactinemia in a case of aldosterone-producing adrenal adenoma.
Topics: Adrenal Gland Neoplasms; Aldosterone; Female; Humans; Hyperprolactinemia; Middle Aged | 1995 |
[Role of hypothalamo-hypophyseal-adrenal axis in the pathogenesis of arterial hypertension in patients with prolactinoma of the anterior lobe of the hypophysis].
Topics: Adult; Aldosterone; Bromocriptine; Data Interpretation, Statistical; Dopamine; Dopamine Agonists; Fe | 2000 |
Stimulatory effects of hyperprolactinemia on aldosterone secretion in ovariectomized rats.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Aldosterone; Alkaloids; Angiotensin II; A | 2002 |
Adrenal steroid endocrinology--some unsolved problems.
Topics: Adrenal Cortex; Adrenocorticotropic Hormone; Aldosterone; Androstenedione; Circadian Rhythm; Dehydro | 1991 |
Hyperiodotyrosinemia-induced hyperprolactinemia and hyperaldosteronism.
Topics: Adult; Aldosterone; Bromocriptine; Dopamine; Dose-Response Relationship, Drug; Epinephrine; Female; | 1990 |
Lack of prolactin involvement in corticosteroid secretion.
Topics: 17-alpha-Hydroxyprogesterone; Adrenal Cortex Hormones; Adrenal Glands; Adult; Aldosterone; Cosyntrop | 1987 |
Plasma aldosterone response to metoclopramide is unmodified by hyperprolactinemia.
Topics: Adult; Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Middle Aged; Pituitary Neopl | 1987 |
Aldosterone responsiveness to metoclopramide in hyperprolactinaemia.
Topics: Aldosterone; Female; Humans; Hyperprolactinemia; Metoclopramide; Prolactin; Thyrotropin | 1987 |